NCT06794203 Hyperthyroidism as a Potential Predictive of Worse Outcome of Renal Graft
| NCT ID | NCT06794203 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Kidney Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2022-09-02 |
| Primary Completion | 2025-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2022-09-02 with a primary completion date of 2025-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objectives of the study are: to research the association, if any, between the occurrence of thyroid function changes in the immediate post-transplant period and the prognosis of the transplant itself; identify any risk factors for the occurrence of thyroid disorders In the immediate post-transplant period.
Eligibility Criteria
Inclusion Criteria: * Subjects transplanted at our Center; * Subjects whose 3-month follow-up is available; * Age ≥18 years; * Availability of clinical and laboratory data regarding thyroid function trends in the immediate post-transplant period (within 30 days after transplantation); * Subjects giving informed consent to participate. Exclusion Criteria: * None.
Contact & Investigator
Gaetano La Manna, MD
PRINCIPAL INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Frequently Asked Questions
Who can join the NCT06794203 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Kidney Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06794203 currently recruiting?
Yes, NCT06794203 is actively recruiting participants. Contact the research team at gaetano.lamanna@unibo.it for enrollment information.
Where is the NCT06794203 trial being conducted?
This trial is being conducted at Bologna, Italy.
Who is sponsoring the NCT06794203 clinical trial?
NCT06794203 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Gaetano La Manna, MD at IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.